Posted by Michael Wonder on 21 Oct 2017
Rising cancer drug costs in the USA
20 October 2017 - The price of patented cancer drugs in the USA rises steadily after their launch, according to a study by Noa Gordon (Rabin Medical Centre, Petah Tikva, Israel) and colleagues.
The researchers calculated the monthly, annual, and cumulative changes in the cost of 24 patented injectable cancer medications that obtained US FDA approval between 1996 and 2012.
